BackSummary
Aspire Biopharma Holdings filed a Certificate of Amendment to effect a 1-for-30 reverse stock split of its common stock, effective May 11, 2026.
Key takeaways
- 1-for-30 reverse stock split of common stock filed on May 11, 2026.
- No fractional shares will be issued; fractional shares rounded up to nearest whole share.
- Trading symbol remains 'ABSP'; new CUSIP number is 738920305.
- Reverse split is intended to meet listing requirements or adjust share price.
- Certificate of Amendment filed with Delaware Secretary of State.